RELIEF THERAPEUTICS HOLDING/ CH1251125998 /
| 15/11/2024 16:42:32 | Chg. -1.42 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.02CHF | -19.09% | 491 Turnover: 2,955.82 |
-Bid Size: - | -Ask Size: - | 85.65 mill.CHF | - | - |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 0.0000 | 0.0000 | 0.0000 | .0400 | ||||||
| Intangible Assets | 30.8000 | 35.2000 | 19.6000 | 30.8000 | 192.3000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | .4000 | 0.0000 | ||||||
| Fixed Assets | 30.8000 | 35.2000 | 19.6000 | 31.2000 | 196.6000 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | .4000 | ||||||
| Accounts Receivable | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 1.3000 | ||||||
| Cash and Cash Equivalents | .1000 | .4000 | .2000 | 38.1000 | 44.8000 | ||||||
| Current Assets | .2000 | .4000 | .3000 | 46.9000 | 55 | ||||||
| Total Assets | 31 | 35.6000 | 19.9000 | 78 | 251.6000 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .5000 | .1000 | .3000 | 1.4000 | 1.7000 | ||||||
| Long-term debt | - | - | - | - | .4000 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | .9000 | 1.7000 | ||||||
| Provisions | 7.5000 | 7.5000 | 2.7000 | 4.3000 | 57.1000 | ||||||
| Liabilities | 10 | 14.3000 | 4.5000 | 11 | 70.1000 | ||||||
| Share Capital | 20.1000 | 20.9000 | 21.1000 | 32.5000 | 44.1000 | ||||||
| Total Equity | 20.9000 | 21.3000 | 14.3000 | 67 | 181.5000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 31 | 35.6000 | 19.9000 | 78 | 251.6000 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 0.0000 | .6000 | 0.0000 | 0.0000 | 3.3000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -1.7000 | -.5000 | -12.1000 | -9.1000 | -34.3000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -1.9000 | -.4000 | -12.2000 | -6.3000 | -35.5000 | ||||||
| Income Taxes | -1 | 0.0000 | 4.7000 | -1.5000 | .8000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -2.9000 | -.4000 | -7.5000 | -7.8000 | -34.3000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -1.2000 | -.6000 | -.7000 | -18.3000 | -35.7000 | ||||||
| Cash Flow from Investing Activities | 0.0000 | 0.0000 | 0.0000 | 3 | -30.3000 | ||||||
| Cash Flow from Financing | .9000 | .7000 | .6000 | 58.2000 | 67.7000 | ||||||
| Decrease / Increase in Cash | -.3000 | .1000 | -.1000 | 43 | 1.7000 | ||||||
| Employees | - | - | - | - | - | ||||||
